Celularity Inc. Earnings Per Share, Basic and Diluted
Celularity Inc. (CELU) reported Earnings Per Share, Basic and Diluted of -$0.48 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-16
- Celularity Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.48.
- Celularity Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was $0.00.
- Celularity Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$3.40, a 8600.00% decline year-over-year.
- Celularity Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.07.
- Celularity Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.49.
- Celularity Inc. earnings per share, basic and diluted for fiscal 2020 was -$11.31, a 11410.00% decline from fiscal 2019.
- Celularity Inc. earnings per share, basic and diluted for fiscal 2019 was $0.10.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 4 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.48 10-Q · filed 2022-05-16 | ||||||||
| 2021-12-31 | -$1.49 10-K · filed 2022-03-31 | ||||||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-19 | $0.00 10-Q · filed 2021-08-19 | |||||||
| 2021-03-31 | -$3.40 10-Q · filed 2022-05-16 | $0.00 10-Q · filed 2021-05-24 | |||||||
| 2020-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$11.31 10-K · filed 2022-03-31 | -$0.45 10-K · filed 2021-03-04 | ||||
| 2020-09-30 | -$0.02 10-Q · filed 2020-11-16 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-08-19 | -$0.05 10-Q · filed 2020-11-16 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-08-19 | |||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-19 | -$0.02 10-Q · filed 2020-08-13 | $0.04 10-Q · filed 2021-08-19 | -$0.03 10-Q · filed 2020-08-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-08-19 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-08-19 | |||
| 2020-03-31 | $0.04 10-Q · filed 2021-05-24 | -$0.01 10-Q · filed 2020-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-05-24 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-05-24 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-05-24 | ||||
| 2019-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-05-24 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-05-24 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-05-24 | $0.10 10-K/A · filed 2021-05-24 | -$0.03 10-K · filed 2020-03-24 | ||||
| 2019-09-30 | -$0.01 10-Q · filed 2020-11-16 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.02 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | ||||||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-24 | ||||||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |